News

News Subscription

May 02. 2019
Basilea's partner Avir Pharma has launched antifungal Cresemba® (isavuconazole) in Canada
Read more
Download
Apr 12. 2019
Basilea reports isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Read more
Download
Apr 10. 2019
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
Read more
Download
Feb 19. 2019
Basilea reports strong revenue growth and significant pipeline progress for full-year 2018
Read more
Download
Feb 08. 2019
Strong European Cresemba® (isavuconazole) sales trigger USD 5 million milestone payment to Basilea from Pfizer
Read more
Download
Feb 07. 2019
Basilea announces change in the Management Committee - Adesh Kaul appointed CFO
Read more
Download
Jan 24. 2019
Basilea announces collaboration to study derazantinib and atezolizumab (Tecentriq®) in urothelial cancer
Read more
Download
Jan 09. 2019
Basilea reports positive interim results from registrational phase 2 study with oncology drug candidate derazantinib in intrahepatic cholangiocarcinoma (iCCA)
Read more
Download
Jan 07. 2019
Basilea reports strong, higher than expected preliminary revenue of CHF 133 million for financial year 2018
Read more
Download
Jan 04. 2019
Basilea presenting at the 37th Annual J. P. Morgan Healthcare Conference - delivering on its strategy
Read more
Download